https://www.selleckchem.com/pr....oducts/Nafamostat-me
sing patients presenting with endocrine conditions, as this could prompt cascade testing and appropriate genetic counselling where necessary. Primary hyperparathyroidism (PHPT) is a disease caused by overactive parathyroid glands with consequent hypercalcaemia. The main cause in 85-90% of the cases is the presence of a solitary parathyroid adenoma. The most common presentation is with asymptomatic hypercalcaemia diagnosed on routine biochemical testing. Although low serum phosphate levels are an associated finding in primary